Non-insulin dependent diabetes mellitus (NIDDM) in minority youth: Research priorities and needs

Clinical Pediatrics

Volumn 37, Issue 2, 1998, Pages 143-152

  Rosenbloom, Arlan L ^a   House, Dorlinda V ^a   Winter, William E ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD NUTRITION; CONFERENCE PAPER; DIET; ENVIRONMENTAL FACTOR; ETHNOLOGY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN RESISTANCE; JUVENILE DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIMARY PREVENTION; RISK FACTOR; UNITED STATES;

EID: 0031939332     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289803700212     Document Type: Conference Paper

References (48)

1. Savage PJ, Bennett PH, Senter RG, Miller M. High prevalence of diabetes in young Pima Indians. Diabetes. 1979; 28:937-942.
2. Harris SB, Perkins BA, Whalen-Brough E. Non-insulin dependent diabetes mellitus among First Nations children. New entity among First Nations people of northwestern Ontario. Can Fam Physician. 1996;42:869-876.
3. Dean HE, Mandy RLL, Miffed M. Non-insulin dependent diabetes mellitus in Indian children in Manitoba. Can Med Assoc J. 1992;147:52-57.
4. Pinnas-Hamill O, Dolan LM, Daniels SR, et al. Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr. 1996; 128:608-615.
5. Martin MM, Martin ALA. Obesity, hyperinsulinism, and diabetes mellitus in childhood. J Pediatr. 1973;82:192-201.
6. Rosenbloom AL, Wheeler L, Bianchi R, et al. Age-adjusted analysis of insulin responses during normal and abnormal oral glucose tolerance tests in children and adolescents. Diabetes. 1975;24:820-828.
7. Morrison EY StA, Ragoobirsingh D, Thompson H, et al. Phasic insulin dependent diabetes mellitus: manifestations and cellular mechanisms. J Clin Endocrinol Metab. 1995;80:1996-2001.
8. Tattersall RB, Fajans SS. A difference between the inheritance of classic juvenile-onset and maturity-onset type diabetes of young people. Diabetes. 1975;24:44-53.
9. Winter WE, Maclaren NK, Riley WJ, et al. Maturity-onset diabetes of youth in black Americans. N Engl J Med. 1987;316:285-291.
10. House DV, Nakamura M, Wasserfall C, et al. Further evidence that ADM is not an autoimmune disease: studies of GADAb in atypical diabetes (ADM). Clin Chem. 1995;41:S49.
11. Huang W, House DV, Nakamura M, et al. Molecular HLA-DQB1 typing and 1A-2 determinations in atypical diabetes mellitus (ADM). Diabetes. 1996;45(Suppl):80A.
12. House DV, Nakamura M, Maclaren NK, Winter WE. First phase C-peptide responses to intravenous glucose in atypical diabetes mellitus (ADM) of African Americans: evidence of a severe defect in beta cell function. Clin Chem. 1996;42:S235.
13. House DV, Stallings R, Nakamura M, et al. Pathohistology of the pancreas in atypical diabetes mellitus (ADM) of African Americans (AA). Diabetes. 1996;45(Suppl 2):122A.
14. Varga-House DA, Winter WE. African American families with ADM display a high frequency of diabetes. Diabetes. 1994;43(Suppl 1):157A.
15. Cox NJ, Xiang KS, Fajans SS, Bell GI. Mapping diabetes susceptibility genes: lessons learned from search for DNA marker for maturity-onset diabetes of the young. Diabetes. 1992; 41:401-407.
16. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962; 14:353-362.
17. Lillioja S, Mott DM, Howard BV, et al. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med. 1988;318:1217-1225.
18. Martin BC, Warram JH, Krolewski AS, et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992;340:925-929.
19. Arslanian S, Suprasongsin C. Diffences in the in vivo insulin secretion and sensitivity of health black versus white adolescents. J Pediatr. 1996; 12:440-443.
20. Pigon J, Giacca A, Ostenson C-G, et al. Normal hepatic insulin sensitivity in lean, mild non-insulin dependent diabetic patients. J Clin Endocrinol Metab. 1996;81:3702-3708.
21. O'Rahilly S, Turner RC, Matthew D. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin dependent diabetes. N Engl J Med. 1988;318:1225-1230.
22. Phipps K, Barker DJP, Hales CN, et al. Fetal growth and impaired glucose tolerance in men and women. Diabetologia. 1993;36:225-228.
23. Phillips DIW, Barker DJP, Hales CN, et al. Thinness at birth and insulin resistance in adult life. Diabetologia, 1994;37:150-154.
24. McCance DR, Pettit DJ, Hanson RLL, et al. Birthweight and non-insulin dependent diabetes: "thrifty genotype," "thrifty phenotype," or "surviving baby genotype." Br Med J. 1994; 308:942-945.
25. Lithell HO, McKeigue PM, Berglund L, et al. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. Br Med J. 1996;312:406-410.
26. Permutt MA, Chiu KG, Tanizawa Y. Glucokinase and NIDDM: a candidate gene that paid off. Diabetes. 1992;41:1367-1372.
27. Gerbitz K-D, Gempel K, Brdiczka D. Mitochondria and diabetes: genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes. 1996;45:113-126.
28. Dukes ID, Philipson LH. K+ channels: generating excitement in pancreatic β-cells. Diabetes. 1996;45:845-853.
29. Groop LG, Kankuri M, Schalin-Jantti C, et al. Association between polymorphism of the glycogen synthase gene and non-insulin dependent diabetes mellitus. N Engl J Med. 1993;328:10-14.
30. Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY 3). Nature. 1996;384:455-458.
31. Yamagata K, Ruruta H, Oda N, et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY 1). Nature. 1996;384:458-460.
32. Hanis GL, Boerwinkle E, Chakraborty R, et al. A genome-wide search for human non-insulin dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nature Genet. 1996;13:161-166.
33. Nakamura M, House DV, Winter WE. Novel mutation identified in the glucokinase (GCK) genes of a patient with atypical diabetes mellitus (ADM) of African Americans. Diabetes. 1996; 45(Suppl 2):76A.
34. Nakamura M, House DV, Winter WE. A novel homoplasmic point mutation at mitochondrial DNA (mtDNA) nucleotide 3308 in a family with atypical diabetes (ADM) of African Americans (AA). Diabetes. 1997;46(Suppl 1):175A.
35. Caro JF, Sinha MK, Kolaczynski JW, et al. Leptin: the tale of an obesity gene. Diabetes. 1996;45:1455-1462.
36. Kolaczynski JW, Ohannesian JP, Considine RV, et al. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab. 1996;81:4162-4165.
37. Widjaja A, Stratton IM, Horn R, et al. UKPDS 20: plasma leptin, obesity, and plasma insulin in Type 2 diabetic subjects. J Clin Endocrinol Metab. 1997; 82:654-657.
38. 3-adrenergic-receptor gene. N Engl J Med. 1995;333:342-347.
39. 3-adrenergic receptor gene in Nauruans with obesity and non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab. 1996;81:4155-4158.
40. Morrison JA, Alfaro MP, Chair P, et al. Determinants of resting energy expenditure in young black girls and young white girls. J Pediatr. 1996; 129:637-642.
41. Kaplan AS, Zemel BS, Stallings VA. Differences in resting energy expenditure in prepubertal black children and white children. J Pediatr. 1996; 129:643-647.
42. Narayan KMV, Hanson RLL, Pettitt DJ, et al. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM. Diabetes Care. 1996;19:972-978.
43. Linn T, Geyer R, Prassek S, Laube H. Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin dependent diabetes mellitus, J Clin Endocrinol Metab. 1996; 81:3938-3943.
44. Perseghin G, Price TB, Petersen KF, et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med. 1996;335:1357-1362.
45. Marfella R, Acampora R, Verrazzo G, et al. Metformin improves hemodynamic and rheologic responses to Larginine in NIDDM patients. Diabetes Care. 1996:19:934-939.
46. Hermann LS, Schersten B, Bitzen PO, et al. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. Diabetes Care. 1994; 17:1100-1109.
47. Edelman SV. Troglitazone: a new and unique oral antidiabetic agent for the treatment of Type 2 diabetes and the insulin resistance syndrome. Clin Diabetes. 1997; March/April:60-65.
48. Martin AE, Montgomery PA. Acarbose: an alpha-glucosidase inhibitor. Am J Health Syst Pharm. 1996;53:2277-2290.